RECRUITING

Prospective Breast Cancer Biospecimen Collection

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Tissue will be procured during a standard of care procedure the patient will already be scheduled to undergo. A one time blood draw will be performed at this time and an optional rectal swab for biome analysis may occur. Follow Up will only consist of chart review to determine date of recurrence, metastases, and/or death

Official Title

Prospective Breast Cancer Biospecimen Collection

Quick Facts

Study Start:2018-05-10
Study Completion:2028-08-11
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04074720

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adults \>18 years old at time of consent
  2. * Subject must be capable to giving informed consent or have an acceptable surrogate capable of giving consent on the subject behalf.
  3. * Patients with carcinoma in situ or invasive breast cancer
  4. * Patient must be undergoing one of the following:
  5. * definitive surgical tumor resection for breast cancer OR
  6. * placement of a vascular access device as a prelude to neoadjuvant therapy for breast cancer OR
  7. * neurosurgical resection of a brain metastasis from primary breast cancer.
  1. * \<18 years old
  2. * Not able to give informed consent and does not have acceptable surrogate capable to giving informed consent.
  3. * Active drug/alcohol dependence or abuse history

Contacts and Locations

Study Contact

Nicole Simone, MD
CONTACT
215-955-6702
Nicole.Simone@jefferson.edu

Principal Investigator

Nicole Simone, MD
PRINCIPAL_INVESTIGATOR
Sidney Kimmel Cancer Center at Thomas Jefferson University

Study Locations (Sites)

Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, 19107
United States

Collaborators and Investigators

Sponsor: Thomas Jefferson University

  • Nicole Simone, MD, PRINCIPAL_INVESTIGATOR, Sidney Kimmel Cancer Center at Thomas Jefferson University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2018-05-10
Study Completion Date2028-08-11

Study Record Updates

Study Start Date2018-05-10
Study Completion Date2028-08-11

Terms related to this study

Additional Relevant MeSH Terms

  • Breast Cancer
  • Invasive Breast Cancer
  • Carcinoma in Situ of the Breast